Trial reportBMC geriatrics2026
Effect of desflurane versus propofol on perioperative neurocognitive disorders in older adults undergoing major urological surgery: a randomized trial.
Trial report in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPerioperative neurocognitive disorders (PND), encompassing postoperative delirium (POD), delayed neurocognitive recovery (dNCR), and postoperative neurocognitive disorder (postoperative NCD), are commom complications of surgery in older adults. Urological surgery carries particularly high risk, with reported incidences reaching 30%. Elevated serum biomarkers in affected patients suggest diagnostic and prognostic utility. Although propofol may reduce postoperative neurocognitive disorder risk compared with other inhalational agents, data on desflurane remain limited despite its rapid pharmacokinetics. This study compared the incidence of POD, dNCR, postoperative NCD, perioperative complications, and biomarker profiles in patients receiving general anesthesia with propofol or desflurane.
methodsThis prospective randomized controlled trial enrolled patients aged 65 years or older undergoing major urological surgery, who were assigned to receive propofol (via target-controlled infusion) or desflurane. Anesthesia depth and cerebral oxygenation were maintained using bispectral index monitoring (40-60) and near-infrared spectroscopy (≥ 60%), respectively. Serum biomarkers were measured at 5 time points (T0-T4). POD was assessed on postoperative days 1-3 using the 3-Minute Diagnostic Interview for Confusion Assessment Method, whereas dNCR and postoperative NCD were assessed using the Montreal Cognitive Assessment between postoperative days 5-9 and at 3-6 months postoperatively, respectively.
resultsAmong 126 patients (propofol, 64; desflurane, 62), overall POD incidence was 14.1% versus 9.8% (P = 0.467), and dNCR incidence at days 5 through 9 was 4.7% versus 11.5% (P = 0.199). However, the number of delirium-present days was statistically significantly greater in the desflurane group (1 [1-1] vs. 1.5 [1-2]; P = 0.044). Interleukin-6 levels increased substantially in both groups, with higher levels on day 3 in patients with POD than in those without (63.8 [42.9-206.4] vs. 31.2 [20.9-69.8] pg/mL; P = 0.009).
conclusionsAlthough PND incidence did not differ between propofol and desflurane, delirium duration was longer with desflurane; however, this exploratory finding should be interpreted cautiously given the small number of delirium cases. Interleukin-6 may serve as a useful biomarker for POD monitoring. Bispectral index and near-infrared spectroscopy-guided anesthesia management may help reduce the incidence of PND.
trial registrationThis study was registered in the Thai Clinical Trials Registry on 24/09/2021 (registration number: TCTR20210924002).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.